MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Seven-Year Outcome of Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease Patients

M. Nassar, I. Senderova, M. Katson, A. Sinai, I. Schlesinger (Haifa, Israel)

Meeting: 2026 International Congress

Keywords: Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Medical Management

Objective: To assess 7-year outcomes of unilateral MRI-guided focused ultrasound (MRgFUS) ventral intermediate nucleus thalamotomy in tremor-dominant Parkinson’s disease (TDPD) patients with levodopa-unresponsive tremor, and to relate outcomes to lesion location using tractography.

Background: Long-term (>5 years) data on MRgFUS outcomes in TDPD are scarce.

Methods Four TDPD patients who completed 7-year follow-up were included (n=4). Tremor was assessed with the Clinical Rating Scale for Tremor (CRST); motor function with the Unified Parkinson’s Disease Rating Scale Part III (UPDRS III), overall and in the treated hemibody (hemi-CRST and hemi-UPDRS). Levodopa equivalent daily dose (LEDD) was calculated. Lesion location was evaluated with tractography.

Method: Four TDPD patients who completed 7-year follow-up were included (n=4). Tremor was assessed with the Clinical Rating Scale for Tremor (CRST); motor function with the Unified Parkinson’s Disease Rating Scale Part III (UPDRS III), overall and in the treated hemibody (hemi-CRST and hemi-UPDRS). Levodopa equivalent daily dose (LEDD) was calculated. Lesion location was evaluated with tractography.

Results: Median age at treatment was 61 years (range 51–66) and median disease duration was 6.5 years (range 2–10). Tremor improved immediately after MRgFUS in all patients. At 7 years, mean hemi-CRST was significantly improved versus baseline (baseline mean 20, range 10–20; 7-year mean 4.5, range 0–7; p = 0.04). Mean total CRST and hemi-UPDRS were also significantly improved at 7 years (p = 0.04), while total UPDRS was not. LEDD increased significantly at 7 years (p = 0.03). Lesions that involved the dentatorubrothalamic tract were associated with sustained tremor improvement. No adverse events were reported.

Conclusion: In this small case series, unilateral MRgFUS thalamotomy produced sustained tremor improvement at 7 years in TDPD patients without procedure-related adverse events. Lesions involving the dentatorubrothalamic tract were associated with long-term benefit; LEDD increased over time as expected.

To cite this abstract in AMA style:

M. Nassar, I. Senderova, M. Katson, A. Sinai, I. Schlesinger. Seven-Year Outcome of Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease Patients [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/seven-year-outcome-of-focused-ultrasound-thalamotomy-in-tremor-dominant-parkinsons-disease-patients/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/seven-year-outcome-of-focused-ultrasound-thalamotomy-in-tremor-dominant-parkinsons-disease-patients/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley